Synthesis and biological properties of iron chelators based on a bis-2-(2-hydroxy-phenyl)-thiazole-4-carboxamide or -thiocarboxamide (BHPTC) scaffold
Authors:
- David Rodriguez-LucenaDavid Rodriguez-Lucena
- François GaboriauFGFrançois Gaboriau
- Freddy RivaultFRFreddy Rivault
- Isabelle J. SchalkISIsabelle J. Schalk
- Gérard LescoatGLGérard Lescoat
- Gaëtan L.A. MislinGMGaëtan L.A. Mislin
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (2) , 689-695
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Iron chelators ICL670 and 311 inhibit HIV-1 transcriptionVirology, 2007
- Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemiaBlood, 2007
- Hepcidin – central regulator of iron metabolismEuropean Journal of Haematology, 2006
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences, 2006
- Bacterial siderophores: the solution stoichiometry and coordination of the Fe(III) complexes of pyochelin and related compoundsJBIC Journal of Biological Inorganic Chemistry, 2006
- Future Chelation Monotherapy and Combination Therapy Strategies in Thalassemia and Other Conditions. Comparison of Deferiprone, Deferoxamine, ICL670, GT56-252, L1NAll and Starch Deferoxamine PolymersHemoglobin, 2006
- The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and CancerPharmacological Reviews, 2005
- Safety and effectiveness of long-term therapy with the oral iron chelator deferiproneBlood, 2003
- Infection of a human hepatoma cell line by hepatitis B virusProceedings of the National Academy of Sciences, 2002
- An improved synthesis of cis,cis-1,3,5-triaminocyclohexane. Synthesis of novel hexadentate ligand derivatives for the preparation of gallium radiopharmaceuticalsBioorganic & Medicinal Chemistry Letters, 1996